Genetic Factors in Deep Vein Thrombosis (DVT) Risk

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on Heart & Cardiovascular Health. Browse all Heart & Cardiovascular Health education

Deep vein thrombosis (DVT) is a blood clot that forms in a deep vein, usually in the leg. It matters because a clot can break loose and travel to the lungs, a dangerous event called pulmonary embolism. DVT is triggered by circumstances — surgery, immobility, long flights, pregnancy — but why the same trigger causes a clot in one person and not another often comes down to inherited differences in how blood clots.

How clots form and why balance matters

Clotting, or coagulation, is a tightly controlled cascade. When a vessel is injured, proteins activate in sequence to form a clot, while a parallel system dissolves clots and keeps blood flowing. Health depends on balance. Inherited variants that push the system toward clotting — collectively called thrombophilias — raise the odds that a normal trigger tips into a dangerous clot. This is why DVT clusters in families and why genetics is a core part of assessing unexplained or recurrent clots.

Factor V Leiden: the most common inherited risk

The best-known thrombophilia is Factor V Leiden, a variant in the F5 gene. Normally, an anticoagulant protein called activated protein C switches off clotting factor V to keep clot formation in check. The Leiden variant makes factor V resistant to that shutdown signal, so clotting continues longer than it should. Carrying one copy raises DVT risk several-fold; two copies raise it more. It is the most common inherited clotting disorder in people of European ancestry, though most carriers never develop a clot without an additional trigger.

Prothrombin G20210A and other variants

The second most common inherited risk is the prothrombin G20210A variant in the F2 gene, which raises levels of prothrombin, a precursor to the enzyme that finishes clot formation. Higher prothrombin means a modestly increased clotting tendency. Rarer but stronger risks come from deficiencies in the natural anticoagulants — genes such as SERPINC1 (antithrombin), PROC (protein C), and PROS1 (protein S). The MTHFR C677T variant is often discussed in this context; while it can raise homocysteine, current evidence does not support it as a strong independent DVT risk factor on its own.

How genetic context fits your biology

These clotting genes belong to broader coagulation and vascular pathways. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including named variants such as those in the coagulation pathway that shape your baseline clotting biology. This is educational context about your predispositions — not a diagnosis, and not a clotting-risk score that replaces clinical testing. If you have had an unexplained clot or a strong family history, formal thrombophilia evaluation belongs with a provider. Genetics is a guide, not a guarantee.

Reducing DVT risk around known triggers

Most DVT prevention targets the situations that combine with genetic tendency. Moving regularly during long travel or bed rest, staying hydrated, and following medical guidance around surgery and pregnancy all reduce risk. People with a known thrombophilia may receive specific preventive measures around high-risk events — but those decisions, including any medication, are made by a provider who weighs your genetics, history, and circumstances together. Genetic insight helps you and your clinician plan ahead; it does not tell you what to take.

Frequently Asked Questions

What is the most common genetic cause of DVT?

Factor V Leiden, a variant in the F5 gene, is the most common inherited clotting disorder in people of European descent. It makes clotting factor V resistant to being switched off, so clots persist longer. Most carriers never develop a clot unless an additional trigger, such as surgery or immobility, is present.

Does a genetic variant mean I will get a blood clot?

No. Inherited thrombophilias like Factor V Leiden and prothrombin G20210A raise the odds but are not deterministic. Most carriers never have a DVT. Clots usually require a genetic tendency plus a trigger, so knowing your predisposition helps you and a provider plan around high-risk situations rather than predicting an outcome.

Can a genetic test diagnose or predict DVT?

No. DVT is diagnosed clinically with imaging such as ultrasound. The Precision Peptide Genetic Test analyzes pathway-level clotting biology for educational context; it does not diagnose, predict, or manage clots. Formal thrombophilia testing and any treatment decisions belong with a qualified healthcare provider.

Is the MTHFR variant a major DVT risk factor?

Current evidence says no. Although the MTHFR C677T variant can raise homocysteine, large studies have not established it as a strong independent cause of DVT. The best-supported inherited risks are Factor V Leiden, prothrombin G20210A, and deficiencies in antithrombin, protein C, and protein S.

Curious how your own genetics shape this pathway? Take the Precision Peptide Genetic Test to see what your DNA reveals about your biology — then bring those insights to a conversation with your healthcare provider.

This article is part of the PlexusDx Education Hub. Browse all Heart & Cardiovascular Health education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.